Migrastatin analogues target fascin to block tumour metastasis

  • A Corrigendum to this article was published on 20 July 2011

Abstract

Tumour metastasis is the primary cause of death of cancer patients. Development of new therapeutics preventing tumour metastasis is urgently needed. Migrastatin is a natural product secreted by Streptomyces1,2, and synthesized migrastatin analogues such as macroketone are potent inhibitors of metastatic tumour cell migration, invasion and metastasis3,4,5,6. Here we show that these migrastatin analogues target the actin-bundling protein fascin to inhibit its activity. X-ray crystal structural studies reveal that migrastatin analogues bind to one of the actin-binding sites on fascin. Our data demonstrate that actin cytoskeletal proteins such as fascin can be explored as new molecular targets for cancer treatment, in a similar manner to the microtubule protein tubulin.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Identification of fascin as a macroketone target.
Figure 2: X-ray crystal structures of fascin and of the complex of fascin and macroketone.
Figure 3: Macroketone-binding site overlaps with one of the actin-binding sites.
Figure 4: Fascin His 474 mutation renders tumour cell migration, invasion and metastasis resistant to macroketone.

Accession codes

Primary accessions

Protein Data Bank

Data deposits

The coordinates and structure factors of crystal structures of fascin and the fascin–macroketone complex have been deposited in the Protein Data Bank under accession numbers 3LLP and 3LNA, respectively.

References

  1. 1

    Nakae, K. et al. Migrastatin, a novel 14-membered lactone from Streptomyces sp. MK929–43F1. J. Antibiot. (Tokyo) 53, 1228–1230 (2000)

  2. 2

    Woo, E. J. et al. Migrastatin and a new compound, isomigrastatin, from Streptomyces platensis . J. Antibiot. (Tokyo) 55, 141–146 (2002)

  3. 3

    Njardarson, J. T., Gaul, C., Shan, D., Huang, X. Y. & Danishefsky, S. J. Discovery of potent cell migration inhibitors through total synthesis: lessons from structure–activity studies of (+)-migrastatin. J. Am. Chem. Soc. 126, 1038–1040 (2004)

  4. 4

    Gaul, C. et al. The migrastatin family: discovery of potent cell migration inhibitors by chemical synthesis. J. Am. Chem. Soc. 126, 11326–11337 (2004)

  5. 5

    Shan, D. et al. Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice. Proc. Natl Acad. Sci. USA 102, 3772–3776 (2005)

  6. 6

    Ju, J. et al. Evaluation of new migrastatin and dorrigocin congeners unveils cell migration inhibitors with dramatically improved potency. Bioorg. Med. Chem. Lett. 18, 5951–5954 (2008)

  7. 7

    Otto, J. J., Kane, R. E. & Bryan, J. Formation of filopodia in coelomocytes: localization of fascin, a 58,000 dalton actin cross-linking protein. Cell 17, 285–293 (1979)

  8. 8

    Bryan, J. & Kane, R. E. Separation and interaction of the major components of sea urchin actin gel. J. Mol. Biol. 125, 207–224 (1978)

  9. 9

    Yamashiro-Matsumura, S. & Matsumura, F. Purification and characterization of an F-actin-bundling 55-kilodalton protein from HeLa cells. J. Biol. Chem. 260, 5087–5097 (1985)

  10. 10

    Vignjevic, D. et al. Formation of filopodia-like bundles in vitro from a dendritic network. J. Cell Biol. 160, 951–962 (2003)

  11. 11

    Vignjevic, D. et al. Role of fascin in filopodial protrusion. J. Cell Biol. 174, 863–875 (2006)

  12. 12

    Adams, J. C. Roles of fascin in cell adhesion and motility. Curr. Opin. Cell Biol. 16, 590–596 (2004)

  13. 13

    Maitra, A. et al. Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47. Am. J. Clin. Pathol. 118, 52–59 (2002)

  14. 14

    Pelosi, G. et al. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids. Lung Cancer 42, 203–213 (2003)

  15. 15

    Hashimoto, Y., Shimada, Y., Kawamura, J., Yamasaki, S. & Imamura, M. The prognostic relevance of fascin expression in human gastric carcinoma. Oncology 67, 262–270 (2004)

  16. 16

    Hashimoto, Y., Skacel, M. & Adams, J. C. Roles of fascin in human carcinoma motility and signaling: prospects for a novel biomarker? Int. J. Biochem. Cell Biol. 37, 1787–1804 (2005)

  17. 17

    Yoder, B. J. et al. The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin. Cancer Res. 11, 186–192 (2005)

  18. 18

    Zigeuner, R., Droschl, N., Tauber, V., Rehak, P. & Langner, C. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique. Urology 68, 518–522 (2006)

  19. 19

    Rodriguez-Pinilla, S. M. et al. Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin. Cancer Res. 12, 1533–1539 (2006)

  20. 20

    Minn, A. J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518–524 (2005)

  21. 21

    Wu, J. M. et al. Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin. Cancer Res. 14, 1938–1946 (2008)

  22. 22

    Ono, S. et al. Identification of an actin binding region and a protein kinase C phosphorylation site on human fascin. J. Biol. Chem. 272, 2527–2533 (1997)

  23. 23

    Mosialos, G. et al. Epstein–Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling protein. J. Virol. 68, 7320–7328 (1994)

  24. 24

    Cant, K. & Cooley, L. Single amino acid mutations in Drosophila fascin disrupt actin bundling function in vivo . Genetics 143, 249–258 (1996)

  25. 25

    Minn, A. J. et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115, 44–55 (2005)

  26. 26

    Yang, S., Zhang, J. J. & Huang, X. Y. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 15, 124–134 (2009)

  27. 27

    Grothey, A., Hashizume, R., Sahin, A. A. & McCrea, P. D. Fascin, an actin-bundling protein associated with cell motility, is upregulated in hormone receptor negative breast cancer. Br. J. Cancer 83, 870–873 (2000)

  28. 28

    Hashimoto, Y., Parsons, M. & Adams, J. C. Dual actin-bundling and protein kinase C-binding activities of fascin regulate carcinoma cell migration downstream of Rac and contribute to metastasis. Mol. Biol. Cell 18, 4591–4602 (2007)

  29. 29

    Vignjevic, D. et al. Fascin, a novel target of β-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res. 67, 6844–6853 (2007)

  30. 30

    van ‘t Veer, L. J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530–536 (2002)

  31. 31

    Shan, D. et al. Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice. Proc. Natl Acad. Sci. USA 102, 3772–3776 (2005)

  32. 32

    Yang, S. & Huang, X. Y. Ca2+ influx through L-type Ca2+ channels controls the trailing tail contraction in growth factor-induced fibroblast cell migration. J. Biol. Chem. 280, 27130–27137 (2005)

  33. 33

    Shan, D. et al. The G protein Gα13 is required for growth factor-induced cell migration. Dev. Cell 10, 707–718 (2006)

  34. 34

    Yang, S., Zhang, J. J. & Huang, X. Y. Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 15, 124–134 (2009)

  35. 35

    Ponomarev, V. et al. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur. J. Nucl. Med. Mol. Imaging 31, 740–751 (2004)

  36. 36

    Doane, A. S. et al. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene 25, 3994–4008 (2006)

  37. 37

    Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126–2132 (2004)

  38. 38

    Vagin, A. A. et al. REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use. Acta Crystallogr. D 60, 2184–2195 (2004)

Download references

Acknowledgements

J.J.Z. and X.Y.H. dedicate this paper to the memory of Yonghong Zhang, who died of cancer on 12 September 2009. We are grateful to W. Gerald (deceased) at Memorial Sloan-Kettering Cancer Center for letting us examine his DNA microarray data on human breast tumour samples for the fascin expression. We thank S. Almo for the fascin plasmid; S. Danishefsky and colleagues for the biotin-conjugated macroketone used in the initial exploration of the conditions for protein purification; members of the J. Massagué laboratory for teaching the use of the IVIS Imaging system; the personnel at the beamlines X6A and X4C of the National Synchrotron Light Source for the beamtime and for assistance; and D. Eliezer, T. Maack, L. Palmer, H. Wu and members of our laboratory for critically reading the manuscript. We thank S. Almo and his colleagues, H. Wu and J. Wu, for help with the crystallization experiments. This work was supported by grants from the National Institutes of Health (CA136837) and the Department of Defense (W81XWH-06-1-0362).

Author Contributions L.C., S.Y., J.J.Z. and X.Y.H. conceived the project. L.C. and S.Y. performed the experiments. S.Y. and J.J. determined the structures. L.C., S.Y., J.J.Z. and X.Y.H. analysed the data and wrote the paper.

Author information

Correspondence to Xin-Yun Huang.

Supplementary information

Supplementary Information

This file contains Supplementary Figures 1-11with legends and Supplementary Tables S1-S4. (PDF 7434 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chen, L., Yang, S., Jakoncic, J. et al. Migrastatin analogues target fascin to block tumour metastasis. Nature 464, 1062–1066 (2010). https://doi.org/10.1038/nature08978

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.